Navigation Links
Endologix to Present at Two Upcoming Conferences
Date:8/3/2011

IRVINE, Calif., Aug. 3, 2011 /PRNewswire/ -- Endologix, Inc. (Nasdaq: ELGX), developer and marketer of minimally invasive treatments for aortic disorders, announced today that John McDermott, President and Chief Executive Officer, is scheduled to present at two upcoming investor conferences.  The first presentation will be at the 31st Annual Canaccord Genuity Growth Conference in Boston, MA.   Event:31st Annual Canaccord Genuity Growth Conference   Date:Thursday, August 11, 2011   Time:10:00 a.m. ETThe second presentation will be at Wedbush Securities 2011 Life Sciences Management Access Conference in New York.

  Event:Wedbush Securities 2011 Life Sciences Management Access Conference   Date:Tuesday, August 16, 2011   Time:1:50 p.m. ETAn audio Web cast of the Company's presentations will be available by visiting the investor relations section of Endologix's Web site at www.endologix.com.  A replay of the presentations will be available for 30 days.

About Endologix, Inc.Endologix, Inc. develops and manufactures minimally invasive treatments for aortic disorders. The Company's focus is endovascular stent grafts for the treatment of abdominal aortic aneurysms (AAA). AAA is a weakening of the wall of the aorta, the largest artery in the body, resulting in a balloon-like enlargement. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The overall patient mortality rate for ruptured AAA is approximately 75%, making it a leading cause of death in the U.S.  The Nellix® Endovascular System and Ventana™ Fenestrated Stent Graft System are investigational devices.  Additional information can be found on Endologix's Web site at www.endologix.com. COMPANY CONTACT:

INVESTOR
'/>"/>

SOURCE Endologix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Endologix Reports 22% Second Quarter 2011 Revenue Growth
2. Endologix and LeMaitre Vascular Enter Early Termination Agreement for European Distribution Rights of Endologix Products
3. Endologix to Report Second Quarter 2011 Financial Results on July 21, 2011
4. Endologix Announces FDA Approval of AFX™ Endovascular AAA System
5. Endologix to Present at the 2011 Bank of America Merrill Lynch Health Care Conference
6. Endologix Files Form 10-K; Nellix Purchase Price Allocation Finalized
7. Endologix to Present at the ROTH 23rd Annual OC Growth Stock Conference
8. Endologix Reports 41% Fourth Quarter 2010 Revenue Growth
9. Endologix Announces Presentation of Favorable Initial PEVAR Trial Results
10. Endologix Announces Favorable Clinical Results for Nellix Technology
11. Endologix to Report Fourth Quarter and Full Year 2010 Financial Results on February 22, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , January 15, 2014 ... subsidiary, BreedIT Ltd., the exclusive worldwide distributor of highly ... announced that on January 7, 2014, the Company,s board ... Ben-Zion Weiner as its new member of ... Weiner held executive positions with Teva Pharmaceutical Industries Ltd ...
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. ... device company developing its Symphony® CGM System as ... announced that Robert F. Doman , Executive ... present at "TEN", Noble Financial Capital Markets, Tenth ... will make a corporate presentation to prospective corporate ...
(Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ... $2.92 per share, net to the seller in cash, ...
Breaking Medicine Technology:BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3
... JERUSALEM , June 2, 2010 Oramed ... announced,today that its subsidiary Oramed Ltd. entered into a joint ... company listed on,the Tel Aviv Stock Exchange, for the establishment ... Under the terms of the agreement, Oramed,will out-license technology to ...
... June 1 The U.S. Food and Drug Administration today approved Prolia, ... for fractures. , , , ... ) , , , ... which the bones become weak and are more likely to break. According to ...
Cached Medicine Technology:Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 2Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd. 3FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 2FDA Approves New Injectable Osteoporosis Treatment for Postmenopausal Women 3
(Date:3/7/2014)... PHOENIX, Ariz. March 7, 2014 In ... of Clinical Oncology (ASCO) has named Dr. Daniel ... Luminaries, celebrating 50 doctors who over the past ... Dr. Von Hoff, M.D., FACP, is Physician-In-Chief and ... (TGen), and Chief Scientific Officer for Scottsdale Healthcare,s ...
(Date:3/7/2014)... had one glass of wine with dinner, but if you,re ... enough to make you a dangerous driver., So, baby boomers, ... used to. , Sara Jo Nixon, Ph.D., a professor in ... Florida and doctoral candidate Alfredo Sklar tested how drinking legally ... age groups: 36 people ages 25 to 35 and 36 ...
(Date:3/7/2014)... study from St. Michael,s Hospital found that, after ... coming into Ontario emergency departments with suicide-related behaviours ... behaviours are incidents of self-inflicted injuries or self-poisonings. ... Evaluative Sciences, the researchers found that from 2002 ... Ontario emergency departments with suicide-related behaviours declined by ...
(Date:3/7/2014)... testing for those men most at risk of prostate ... whole population, a leading scientist from The University of ... has argued at an international conference this week. , ... blood test for prostate cancer once they reach the ... a prostate biopsy if their PSA level is greater ...
(Date:3/6/2014)... rates breathing difficulties on a scale of 0 to ... a study published in the March issue of ... And although a poor score means a higher risk ... spot lung involvement early means that patients can begin ... Stephanie Lee, M.D., M.P.H., research director of Fred Hutchinson ...
Breaking Medicine News(10 mins):Health News:TGen and Scottsdale Healthcare cancer expert Dr. Daniel D. Von Hoff is honored by ASCO 2Health News:For older drivers, study finds, 1 drink may be 1 too many 2Health News:For older drivers, study finds, 1 drink may be 1 too many 3Health News:After years of improving, rates of youth suicide-related behaviors stopped declining 2Health News:New approach to prostate cancer screening needed 2Health News:Early detection helps manage a chronic graft-vs.-host disease complication 2
... Some patients with advanced nonsmall-cell lung cancer (NSCLC) have ... drug cisplatin than another platinum-based drug carboplatin, according ... the National Cancer Institute. The authors conclude that cisplatin ... patients. ,Most clinicians in North America prefer ...
... likely to have elevated markers of inflammation, called inflammatory ... distinguished the men with low testosterone was a ... and diabetes risk factors related to this type of ... more likely to have the metabolic syndrome than men ...
... 2002, fifteen months after the 9/11 terrorist attacks, President George ... Eisenhower Executive Office Building next door to the White ... in laboratories, and we believe that regimes hostile to the ... information that a smallpox attack is imminent. Yet it is ...
... According to a study in the June 6 issue of ... of colorectal tumors. Some previous studies have suggested that ... ,Bernard F. Cole, Ph.D., of Dartmouth Medical School, Hanover, ... prevention of new colorectal adenomas in persons with a history ...
... like some phantasy. They live longer than almost anyone in ... vaccinated, and such scourges of the poor as parasites, ... see a doctor, at low cost, right in the neighborhood. ... indeed stupendous. The recent Michael Moore documentary pouring scorn on ...
... make some of us gain more weight than others- ... molecule called BSX, as scientists from the European ... Nutrition [DIFE], Potsdam, and the University of Cincinnati report ... ,Bsx is the molecular link between spontaneous physical activity ...
Cached Medicine News:Health News:Low Levels of Testosterone may Increase the Risk of Death in Older Men 2Health News:Low Levels of Testosterone may Increase the Risk of Death in Older Men 3Health News:New Smallpox Vaccine Contract: Five Years in the Making 2Health News:The Risk of Colorectal Tumor is Not Reduced With Folic Acid Supplements 2Health News:Cuba is Exporting Healthcare Now 2Health News:Cuba is Exporting Healthcare Now 3Health News:Cuba is Exporting Healthcare Now 4Health News:Cuba is Exporting Healthcare Now 5Health News:Molecular Basis of Obesity-Revealing the Unknown Facts 2
Microbiology QC Slides come with one or two droplets of an air-dried and methanol-fixed microorganism, or a single smear containing a designated microorganism population....
... Well Plate Capability The Equalizer 384 ... Equalizerexpandable and equal tip spacing, choice of two ... In addition, this model allows you to evenly ... and accessing many gels and for use with ...
Each slide contains a high yield of concentrated C. parvum oocysts within the positive control well. A negative control well is also included....
... Slides contain two wells: a ... ATCC ® 3308 in simulated ... containing Streptomyces albus subsp. albus ... sputum. Nocardia Stain Control Slides ...
Medicine Products: